Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Egypt J Immunol ; 30(2): 83-98, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37031410

ABSTRACT

Diabetic retinopathy (DR) is a typical microvascular complication of diabetes mellitus (DM) and it remains one of the leading causes of vision loss worldwide. Studies postulated that a distinct metabolic signature of DR exists and can be resolved from that of diabetes alone. Serum Semaphorin3A (Sema3A) levels have also been found to be correlated with the phenotypes of diabetic retinopathy. We aimed to analyze and identify serum metabolites and serum Sema3A levels that could be useful biomarkers of DR progression. This cross-sectional study included 45 type 2 diabetes (T2D) patients. Diabetic patients were divided into three groups based on the status of their complications: non-DR (NDR, n=15), non-proliferative DR (NPDR, n=15), and proliferative DR (PDR, n=15) groups. Serum metabolomic profiles of these patients were determined by using high-performance liquid chromatography-mass spectrometry (HPLC-MS), and serum Sema3A levels measured by ELISA. Metabolomics analysis revealed a set of metabolites that were altered in the serum of PDR patients as compared with NPDR and NDR groups. Among these metabolites total asymmetric dimethylarginine (ADMA) and Kynurenine were potential predictors of PDR patients. Significantly higher serum levels of Sema3A in PDR patients as compared with NPDR and NDR groups (p < 0.001), their serum levels were positively correlated with the central macular thickness (r= 0.952, p < 0.001) and negatively correlated with the superficial macular density (r=-0.952, p < 0.001). In conclusion, the metabolite signatures identified in this study and serum Sema3A levels could be proposed as biomarkers for DR development and progression in T2D patients. However, Sema3A was superior to metabolomics in the prediction of the severity of DR.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetic Retinopathy , Humans , Diabetic Retinopathy/complications , Diabetic Retinopathy/metabolism , Semaphorin-3A , Diabetes Mellitus, Type 2/complications , Cross-Sectional Studies , Biomarkers
2.
J Biomed Mater Res A ; 98(1): 132-42, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21548067

ABSTRACT

60P2O5-20CaO-(20-x) Na2O-xAg2O and 60P2O5-30CaO-(10-x) Na2O-xAg2O glasses, x = 0, 0.5,1, and 2 mol % were prepared using normal glass melting technique. The antibacterial activity of pressed disks of powdered glass (undoped and silver-doped glass) was investigated against S.aureus, P.aeruginosa, and E.coli micro-organisms using agar disk-diffusion assays at 37 °C for 24 h. The antibacterial activity was deduced from the inhibition zone diameter (IZD), zone of no bacterial growth, measured under the stated experimental conditions. The antibacterial activity increases with the increase in IZD and vice versa. Dissolution of glass in water at 37 °C, pH changes of water during glass dissolution, and concentrations of silver ions released from silver-doped glasses into water during their dissolution were determined. An increase in the concentration of silver ions released from silver-doped glasses into water was observed with increasing time of glass dissolution and with increasing Ag2O content. The tested silver-free and silver-doped glasses demonstrated different antibacterial activity against the tested micro-organisms. For silver-free glasses, an increase in IZD was observed with the increase in the glass dissolution rate and with the decrease in pH of water. Also, the IZD showed an increase with increasing Ag2O content of silver-doped glasses.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Glass/chemistry , Escherichia coli/drug effects , Hydrogen-Ion Concentration/drug effects , Ions , Microbial Sensitivity Tests , Molecular Weight , Pseudomonas aeruginosa/drug effects , Silver/chemistry , Solubility/drug effects , Staphylococcus aureus/drug effects , Time Factors , Water/chemistry
3.
Curr Microbiol ; 51(6): 402-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16328628

ABSTRACT

Bacillus subtilis NRC 33a was able to produce both inducible and constitutive extracellular levansucrase, respectively, using sucrose and glucose as carbon source. The optimal production of the levansucrase was at 30 degrees C. The effect of different nitrogen sources showed that baker's yeast with 2% concentration gave the highest levansucrase activity. Addition of 0.15 g/L MgSO(4) was the most favorable for levansucrase production. The enzymic synthesis of levan was studied using 60% acetone fraction. The results indicated that high enzyme concentrations produced increasing amounts of levan, and hence conversion of fructose to levan reached 84% using 1,000 microg/ml enzyme protein. Sucrose concentration was the most effective factor controlling the molecular weight of the synthesized levan. The conversion of fructose to levan was maximal at 30 degrees C. The time of reaction clearly affected the conversion of fructose to levan, which reached its maximum productivity at 18 hours (92%). Identification of levan indicated that fructose was the building unit of levan.


Subject(s)
Bacillus subtilis/enzymology , Fructans/metabolism , Hexosyltransferases/isolation & purification , Oligosaccharides/metabolism , Culture Media/chemistry , Fructose/metabolism , Hexosyltransferases/biosynthesis , Hexosyltransferases/metabolism , Magnesium Sulfate/metabolism , Molecular Weight , Nitrogen/metabolism , Sucrose/metabolism , Temperature , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...